|
1
|
Fuster V, Rydén LE, Cannom DS, Crijns HJ,
Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe
JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr,
Priori SG, Estes NA III, Ezekowitz MD, Jackman WM, January CT, Lowe
JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK,
Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton
RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG,
Tarkington LG and Yancy CW; American College of Cardiology
Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS
focused updates incorporated into the ACC/AHA/ESC 2006 guidelines
for the management of patients with atrial fibrillation: a report
of the American College of Cardiology Foundation/American Heart
Association Task Force on practice guidelines. Circulation.
123:e269–e367. 2011.
|
|
2
|
Go AS, Hylek EM, Phillips KA, Chang Y,
Henault LE, Selby JV and Singer DE: Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management
and stroke prevention: the AnTicoagulation and Risk Factors in
Atrial Fibrillation (ATRIA) Study. JAMA. 285:2370–2375. 2001.
View Article : Google Scholar
|
|
3
|
Lloyd-Jones DM, Wang TJ, Leip EP, Larson
MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA
and Benjamin EJ: Lifetime risk for development of atrial
fibrillation: the Framingham Heart Study. Circulation.
110:1042–1046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS,
Bailey KR, Abhayaratna WP, Seward JB and Tsang TS: Secular trends
in incidence of atrial fibrillation in Olmsted County, Minnesota,
1980 to 2000, and implications on the projections for future
prevalence. Circulation. 114:119–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf PA, Abbott RD and Kannel WB: Atrial
fibrillation as an independent risk factor for stroke: the
Framingham Study. Stroke. 22:983–988. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Benjamin EJ, Wolf PA, D’Agostino RB,
Silbershatz H, Kannel WB and Levy D: Impact of atrial fibrillation
on the risk of death: the Framingham Heart Study. Circulation.
98:946–952. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Magnani JW, Rienstra M, Lin H, Sinner MF,
Lubitz SA, McManus DD, Dupuis J, Ellinor PT and Benjamin EJ: Atrial
fibrillation: current knowledge and future directions in
epidemiology and genomics. Circulation. 124:1982–1993. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coyne KS, Paramore C, Grandy S, Mercader
M, Reynolds M and Zimetbaum P: Assessing the direct costs of
treating nonvalvular atrial fibrillation in the United States.
Value Health. 9:348–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Darbar D, Herron KJ, Ballew JD, Jahangir
A, Gersh BJ, Shen WK, Hammill SC, Packer DL and Olson TM: Familial
atrial fibrillation is a genetically heterogeneous disorder. J Am
Coll Cardiol. 41:2185–2192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ellinor PT, Yoerger DM, Ruskin JN and
MacRae CA: Familial aggregation in lone atrial fibrillation. Hum
Genet. 118:179–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arnar DO, Thorvaldsson S, Manolio TA,
Thorgeirsson G, Kristjansson K, Hakonarson H and Stefansson K:
Familial aggregation of atrial fibrillation in Iceland. Eur Heart
J. 27:708–712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Junttila MJ, Raatikainen MJ, Perkiömäki
JS, Hong K, Brugada R and Huikuri HV: Familial clustering of lone
atrial fibrillation in patients with saddleback-type ST-segment
elevation in right precordial leads. Eur Heart J. 28:463–468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Christophersen IE, Ravn LS,
Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen JH and
Christensen K: Familial aggregation of atrial fibrillation: a study
in Danish twins. Circ Arrhythm Electrophysiol. 2:378–383. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Fang WY and Liu X: Familial aggregation of lone atrial
fibrillation in the Chinese population. Intern Med. 49:2385–2391.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lubitz SA, Yin X, Fontes JD, Magnani JW,
Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D,
Larson MG, Ellinor PT and Benjamin EJ: Association between familial
atrial fibrillation and risk of new-onset atrial fibrillation.
JAMA. 304:2263–2269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fox CS, Parise H, D’Agostino RB Sr,
Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA and Benjamin EJ:
Parental atrial fibrillation as a risk factor for atrial
fibrillation in offspring. JAMA. 291:2851–2855. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brugada R, Tapscott T, Czernuszewicz GZ,
Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A,
Bachinski LL and Roberts R: Identification of a genetic locus for
familial atrial fibrillation. N Engl J Med. 336:905–911. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ellinor PT, Shin JT, Moore RK, Yoerger DM
and MacRae CA: Locus for atrial fibrillation maps to chromosome
6q14-16. Circulation. 107:2880–2883. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang
Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y,
Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J and Huang W: KCNQ1
gain-of-function mutation in familial atrial fibrillation. Science.
299:251–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oberti C, Wang L, Li L, Dong J, Rao S, Du
W and Wang Q: Genome-wide linkage scan identifies a novel genetic
locus on chromosome 5p13 for neonatal atrial fibrillation
associated with sudden death and variable cardiomyopathy.
Circulation. 110:3753–3759. 2004. View Article : Google Scholar
|
|
21
|
Zhang X, Chen S, Yoo S, Chakrabarti S,
Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, de la Fuente R,
Wang L, Chen Q and Wang QK: Mutation in nuclear pore component
NUP155 leads to atrial fibrillation and early sudden cardiac death.
Cell. 135:1017–1027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Volders PG, Zhu Q, Timmermans C, Eurlings
PM, Su X, Arens YH, Li L, Jongbloed RJ, Xia M, Rodriguez LM and
Chen YH: Mapping a novel locus for familial atrial fibrillation on
chromosome 10p11-q21. Heart Rhythm. 4:469–475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Darbar D, Hardy A, Haines JL and Roden DM:
Prolonged signal-averaged P-wave duration as an intermediate
phenotype for familial atrial fibrillation. J Am Coll Cardiol.
51:1083–1089. 2008. View Article : Google Scholar
|
|
24
|
Olesen MS, Bentzen BH, Nielsen JB,
Steffensen AB, David JP, Jabbari J, Jensen HK, Haunsø S, Svendsen
JH and Schmitt N: Mutations in the potassium channel subunit KCNE1
are associated with early-onset familial atrial fibrillation. BMC
Med Genet. 13:242012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Xia M, Jin Q, Bendahhou S, Shi J
and Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R,
Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J
and Chen Y: Identification of a KCNE2 gain-of-function mutation in
patients with familial atrial fibrillation. Am J Hum Genet.
75:899–905. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lundby A, Ravn LS, Svendsen JH, Hauns S,
Olesen SP and Schmitt N: KCNE3 mutation V17M identified in a
patient with lone atrial fibrillation. Cell Physiol Biochem.
21:47–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng Z, Tan C, Teng S, Chen J, Su S, Zhou
X, Wang F, Zhang S, Gu D, Makielski JC and Pu J: The single
nucleotide polymorphisms of I(Ks) potassium channel genes and their
association with atrial fibrillation in a Chinese population.
Cardiology. 108:97–103. 2007. View Article : Google Scholar
|
|
28
|
Ravn LS, Aizawa Y, Pollevick GD,
Hofman-Bang J, Cordeiro JM, Dixen U, Jensen G, Wu Y, Burashnikov E,
Haunso S, Guerchicoff A, Hu D, Svendsen JH, Christiansen M and
Antzelevitch C: Gain of function in IKs secondary to a mutation in
KCNE5 associated with atrial fibrillation. Heart Rhythm. 5:427–435.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong K, Bjerregaard P, Gussak I and
Brugada R: Short QT syndrome and atrial fibrillation caused by
mutation in KCNH2. J Cardiovasc Electrophysiol. 16:394–396. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia M, Jin Q, Bendahhou S, He Y, Larroque
MM and Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J,
Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings
P, Barhanin J and Chen Y: A Kir2.1 gain-of-function mutation
underlies familial atrial fibrillation. Biochem Biophys Res Commun.
332:1012–1019. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Delaney JT, Muhammad R, Blair MA, Kor K,
Fish FA, Roden DM and Darbar D: A KCNJ8 mutation associated with
early repolarization and atrial fibrillation. Europace.
14:1428–1432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olson TM, Alekseev AE, Liu XK, Park S,
Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A and
Terzic A: Kv1.5 channelopathy due to KCNA5 loss-of-function
mutation causes human atrial fibrillation. Hum Mol Genet.
15:2185–2191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Li J, Lin X, Yang Y, Hong K, Wang
L, Liu J, Li L, Yan D, Liang D, Xiao J, Jin H, Wu J, Zhang Y and
Chen YH: Novel KCNA5 loss-of-function mutations responsible for
atrial fibrillation. J Hum Genet. 54:277–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Olson TM, Michels VV, Ballew JD, Reyna SP,
Karst ML, Herron KJ, Horton SC, Rodeheffer RJ and Anderson JL:
Sodium channel mutations and susceptibility to heart failure and
atrial fibrillation. JAMA. 293:447–454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Watanabe H, Darbar D, Kaiser DW,
Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ and Roden
DM: Mutations in sodium channel beta1- and beta2-subunits
associated with atrial fibrillation. Circ Arrhythm Electrophysiol.
2:268–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang P, Yang Q, Wu X, Yang Y, Shi L, Wang
C, Wu G, Xia Y, Yang B, Zhang R, Xu C, Cheng X, Li S, Zhao Y, Fu F,
Liao Y, Fang F, Chen Q, Tu X and Wang QK: Functional
dominant-negative mutation of sodium channel subunit gene SCN3B
associated with atrial fibrillation in a Chinese GeneID population.
Biochem Biophys Res Commun. 398:98–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Olesen MS, Jespersen T, Nielsen JB, Liang
B, Møller DV, Hedley P, Christiansen M, Varró A, Olesen SP, Haunsø
S, Schmitt N and Svendsen JH: Mutations in sodium channel β-subunit
SCN3B are associated with early-onset lone atrial fibrillation.
Cardiovasc Res. 89:786–793. 2011.
|
|
38
|
Hodgson-Zingman DM, Karst ML, Zingman LV,
Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett
JC Jr and Olson TM: Atrial natriuretic peptide frameshift mutation
in familial atrial fibrillation. N Engl J Med. 359:158–165. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ren X, Xu C, Zhan C, Yang Y, Shi L, Wang
F, Wang C, Xia Y, Yang B, Wu G, Wang P, Li X, Wang D, Xiong X, Liu
J, Liu Y, Liu M, Liu J, Tu X and Wang QK: Identification of NPPA
variants associated with atrial fibrillation in a Chinese GeneID
population. Clin Chim Acta. 411:481–485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thibodeau IL, Xu J, Li Q, Liu G, Lam K,
Veinot JP, Birnie DH, Jones DL, Krahn AD, Lemery R, Nicholson BJ
and Gollob MH: Paradigm of genetic mosaicism and lone atrial
fibrillation: physiological characterization of a connexin
43-deletion mutant identified from atrial tissue. Circulation.
122:236–244. 2010. View Article : Google Scholar
|
|
41
|
Gollob MH, Jones DL, Krahn AD, Danis L,
Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F,
Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L and Bai D:
Somatic mutations in the connexin 40 gene (GJA5) in atrial
fibrillation. N Engl J Med. 354:2677–2688. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Jiang WF, Fang WY and Liu X: Connexin40 nonsense mutation in
familial atrial fibrillation. Int J Mol Med. 26:605–610.
2010.PubMed/NCBI
|
|
43
|
Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW,
Shi HF, Jiang WF and Fang WY: Novel connexin40 missense mutations
in patients with familial atrial fibrillation. Europace.
12:1421–1427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mahida S, Lubitz SA, Rienstra M, Milan DJ
and Ellinor PT: Monogenic atrial fibrillation as pathophysiological
paradigms. Cardiovasc Res. 89:692–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mommersteeg MT, Christoffels VM, Anderson
RH and Moorman AF: Atrial fibrillation: a developmental point of
view. Heart Rhythm. 6:1818–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Akazawa H and Komuro I: Cardiac
transcription factor Csx/Nkx2-5: Its role in cardiac development
and diseases. Pharmacol Ther. 107:252–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Peterkin T, Gibson A, Loose M and Patient
R: The roles of GATA-4, -5 and -6 in vertebrate heart development.
Semin Cell Dev Biol. 16:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Posch MG, Boldt LH, Polotzki M, Richter S,
Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in
the cardiac transcription factor GATA4 in patients with lone atrial
fibrillation. Eur J Med Genet. 53:201–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang YQ, Wang MY, Zhang XL, Tan HW, Shi
HF, Jiang WF, Wang XH, Fang WY and Liu X: GATA4 loss-of-function
mutations in familial atrial fibrillation. Clin Chim Acta.
412:1825–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
52
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.PubMed/NCBI
|
|
55
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu
YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6
loss-of-function mutation in atrial fibrillation. Eur J Med Genet.
55:520–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
|
58
|
Zhang Y, Rath N, Hannenhalli S, Wang Z,
Cappola T, Kimura S, Atochina-Vasserman E, Lu MM, Beers MF and
Morrisey EE: GATA and Nkx factors synergistically regulate
tissue-specific gene expression and development in vivo.
Development. 134:189–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pradhan L, Genis C, Scone P, Weinberg EO,
Kasahara H and Nam HJ: Crystal structure of the human NKX2.5
homeodomain in complex with DNA target. Biochemistry. 51:6312–6319.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tanaka M, Chen Z, Bartunkova S, Yamasaki N
and Izumo S: The cardiac homeobox gene Csx/Nkx2.5 lies genetically
upstream of multiple genes essential for heart development.
Development. 126:1269–1280. 1999.PubMed/NCBI
|
|
61
|
Warren SA, Terada R, Briggs LE,
Cole-Jeffrey CT, Chien WM, Seki T, Weinberg EO, Yang TP, Chin MT,
Bungert J and Kasahara H: Differential role of Nkx2-5 in activation
of the atrial natriuretic factor gene in the developing versus
failing heart. Mol Cell Biol. 31:4633–4645. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Haïssaguerre M, Jaïs P, Shah DC, Takahashi
A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P and
Clémenty J: Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. N Engl J Med.
339:659–666. 1998.PubMed/NCBI
|
|
63
|
Mommersteeg MT, Brown NA, Prall OW, de
Gier-de Vries C, Harvey RP, Moorman AF and Christoffels VM: Pitx2c
and Nkx2-5 are required for the formation and identity of the
pulmonary myocardium. Circ Res. 101:902–909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mommersteeg MT, Hoogaars WM, Prall OW, de
Gier-de Vries C, Wiese C, Clout DE, Papaioannou VE, Brown NA,
Harvey RP, Moorman AF and Christoffels VM: Molecular pathway for
the localized formation of the sinoatrial node. Circ Res.
100:354–362. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang J, Xin YF, Liu XY, Liu ZM, Wang XZ
and Yang YQ: A novel NKX2-5 mutation in familial ventricular septal
defect. Int J Mol Med. 27:369–375. 2011.PubMed/NCBI
|
|
67
|
Liu XY, Wang J, Yang YQ, Zhang YY, Chen
XZ, Zhang W, Wang XZ, Zheng JH and Chen YH: Novel NKX2-5 mutations
in patients with familial atrial septal defects. Pediatr Cardiol.
32:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang J, Liu XY and Yang YQ: Novel NKX2-5
mutations responsible for congenital heart disease. Genet Mol Res.
10:2905–2915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang J, Fang M, Liu XY, Xin YF, Liu ZM,
Chen XZ, Wang XZ, Fang WY, Liu X and Yang YQ: A novel GATA4
mutation responsible for congenital ventricular septal defects. Int
J Mol Med. 28:557–564. 2011.PubMed/NCBI
|
|
71
|
Liu XY, Wang J, Zheng JH, Bai K, Liu ZM,
Wang XZ, Liu X, Fang WY and Yang YQ: Involvement of a novel GATA4
mutation in atrial septal defects. Int J Mol Med. 28:17–23.
2011.PubMed/NCBI
|
|
72
|
Wang J, Luo XJ, Xin YF, Liu Y, Liu ZM,
Wang Q, Li RG, Fang WY, Wang XZ and Yang YQ: Novel GATA6 mutations
associated with congenital ventricular septal defect or tetralogy
of fallot. DNA Cell Biol. 31:1610–1617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yang YQ, Li L, Wang J, Liu XY, Chen XZ,
Zhang W, Wang XZ, Jiang JQ, Liu X and Fang WY: A novel GATA4
loss-of-function mutation associated with congenital ventricular
septal defect. Pediatr Cardiol. 33:539–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with congenital
ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.PubMed/NCBI
|
|
75
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
